Prof. Hui Chen 陈辉
Chief Physician, Professor
Department of Urology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and systemic treatment of urologic cancers, including prostate, kidney, bladder, testicular, and penile cancer. Expertise in robotic and laparoscopic procedures, minimally invasive surgery, and therapies such as immunotherapy, targeted therapy, and chemotherapy.
Dr. Chen earned an MD from Harbin Medical University (1996), a master’s in surgery (2000), and a PhD in oncology (2009). After postdoctoral training, Dr. Chen joined Harbin Medical University Cancer Hospital, serving as Director of the Second Urology Department. Research focuses on bladder tumor treatments. Dr. Chen has published over 10 domestic papers and 8 SCI-indexed articles.
Professional roles
- Chair, Urology Branch, Heilongjiang Medical Promotion Association
- Vice Chair, Urogenital Tumor Society, Heilongjiang Anti-Cancer Association
- Vice Chair, Urology Branch, Heilongjiang Medical Doctor Association
- Standing Committee Member, Northeast Young Urologists Committee
Name order: in Chinese the family name comes first (Chen Hui). Papers usually list the name as Hui Chen or Chen H.
Selected publications
31 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Free Radic Biol Med, 2026 (senior author): Targeted degradation of ATP7B via a novel autophagy-targeting chimera promotes cuproptosis to potentiate anti-tumor immunity in clear cell renal cell carcinoma. PubMed 42580537
- Proc Natl Acad Sci U S A, 2026 (first author): CD28 costimulation is organized by signaling condensates and counteracted by PD-1. PubMed 42905561
- EMBO Rep, 2026 (first author): Mechanical force regulates the inhibitory function of PD-1. PubMed 41741724
- Front Endocrinol (Lausanne), 2024 (senior author): Association between different insulin resistance indices and all-cause mortality in patients with diabetic kidney disease: a prospective cohort study. PubMed 39872311
- Front Nutr, 2024 (senior author): Association between the composite dietary antioxidant index and the prevalence and recurrence of kidney stones: results of a nationwide survey. PubMed 38962435
- Cancer Sci, 2024 (senior author): LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression. PubMed 38476086
- Proc Natl Acad Sci U S A, 2023 (first author): Self-programmed dynamics of T cell receptor condensation. PubMed 37399423
- Urol Oncol, 2020 (senior author): Efficacy and safety of apatinib monotherapy in metastatic renal cell carcinoma (mRCC) patients: A single-arm observational study. PubMed 32839081
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion